The History of Tumor Vaccines, and Why the Newest RNA Vaccines May Work Where Others Could Not

Margaret Callahan, MD, PhD, is a board-certified medical oncologist at the University of Connecticut. Previously, she was the Immunotherapeutics Program Research Director at the Memorial Sloan Kettering Cancer Center, specializing in the use of immunotherapies to treat melanoma and other cancers. She worked in the Immunotherapeutics Clinical Core, which is a specialized center for Phase 1 studies of new immunotherapy agents, and also worked on the Melanoma and Sarcoma Service. Dr Callahan’s research is focused on the development of new ways to use the immune system to treat cancer. Her current research aims to better understand how immunotherapy can be used to help patients with cancer and to expand this promising treatment modality into new areas.